CELEBRATION, Fla. – A surgical team at AdventHealth recently became the first in the state to use a groundbreaking new surgical robot.
Dr. Vipul Patel, a world leader in robot-assisted prostatectomy procedures, performed the first procedure in early April using the da Vinci 5 system, and will continue to utilize the new surgical robot.
The da Vinci 5 succeeds the da Vinci Xi, which has been in wide use at AdventHealth and health systems around the world since its debut in 2014. It has been used in more than 7 million procedures to date, according to manufacturer Intuitive.
“This new technology is the next step in the future of robotic surgery,” Patel said. “The da Vinci 5 promises new innovation to facilitate improved surgeon comfort and data feedback.”
Among the new features:
- More ergonomic design for surgeon comfort
- Next-generation 3D display
- 10,000 times the computing power of the previous model
- Connectivity with other technology in the OR that may streamline procedures and save time for surgical teams.
Robotic surgery is minimally invasive, and has a track record indicating improved outcomes and better patient experience in certain procedures compared to traditional open surgeries or minimally invasive laparoscopic procedures.
“At AdventHealth, we pride ourselves on being leaders in health care innovation,” said Amanda Maggard, CEO of AdventHealth Celebration. “Bringing this technology right here to Celebration allows us to provide leading-edge treatment that’s convenient and close to home.”
12 items. To interact with these items, press Control-Option-Shift-Right Arrow. These items are in a slider. To advance slider forward, press Shift-Command-Right Arrow. To advance slider backward, press Shift-Command-Left Arrow.
News
AdventHealth Neuroscience Institute Among First in U.S. to Offer Phase IIa Clinical Trial of Troculeucel for Moderate Alzheimer’s Disease
While most clinical trials for Alzheimer’s disease have focused on patients with early or mild cognitive impairment, roughly 30% of those with Alzheimer’s have moderate stage disease for which there...
News
AdventHealth Translational Research Institute Selected as Clinical Site for National Study of Muscle, Mobility and Aging (SOMMA)
Under the leadership of Scientific Director and Principal Investigator Bret H. Goodpaster, PhD, the AdventHealth Translational Research Institute (TRI) is now enrolling men and women 70 years of age...
News
AdventHealth Neuroscience Institute Administers First Dose of Investigative NK Cell Therapy to Person with Alzheimer’s Disease
Under a single compassionate use Investigational New Drug (IND) authorization cleared by the U.S. Food and Drug Administration (FDA), the AdventHealth Neuroscience Institute worked with NKGen Biotech...
